Tea contains potent inhibitors of tyrosine phosphatase PTP1B

Biochemical and Biophysical Research Communications

Volumn 407, Issue 1, 2011, Pages 98-102

  Ma, Junfeng ^a,b   Li, Zhe ^a   Xing, Shu ^a,b   Ho, Wan Ting Tina ^a   Fu, Xueqi ^b   Zhao, Zhizhuang Joe ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b JILIN UNIVERSITY   (China)

Author keywords

Diabetes; Inhibitor; Obesity; Polyphenol; Tea; Tyrosine phosphatase

Indexed keywords

BLACK TEA EXTRACT; CATECHIN; CELL PROTEIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GALLOCATECHIN GALLATE; GREEN TEA EXTRACT; MONOPHENOL MONOOXYGENASE; POLYPHENOL DERIVATIVE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; TYROSINE; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CATALYSIS; CELL CULTURE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVITY; FRACTIONATION; IC 50; NONHUMAN; OXIDATION; PLANT LEAF; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEA;

ANIMALS; CAMELLIA SINENSIS; CATECHIN; CHROMATOGRAPHY, REVERSE-PHASE; HUMANS; MICE; MONOPHENOL MONOOXYGENASE; NIH 3T3 CELLS; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; TEA; TYROSINE;

CAMELLIA SINENSIS;

EID: 79953162197     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.116     Document Type: Article

References (41)

1. Alonso A., Sasin J., Bottini N., et al. Protein tyrosine phosphatases in the human genome. Cell 2004, 117(6):699-711.
2. Andersen J.N., Mortensen O.H., Peters G.H., et al. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 2001, 21:7117-7136.
3. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006, 7:833-846.
4. Mustelin T., Vang T., Bottini N. Protein tyrosine phosphatases and the immune response. Nat. Rev. Immunol. 2005, 5:43-57.
5. Ostman A., Hellberg C., Böhmer F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 2006, 6:307-320.
6. Johnson T.O., Ermolieff J., Jirousek M.R. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat. Rev. Drug Discov. 2002, 1:696-709.
7. Zhang Z.Y., Lee S.Y. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin. Invest. Drugs 2003, 12:223-233.
8. Zhang S., Zhang Z.Y. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discovery Today 2007, 12:373-381.
9. Tonks N.K., Diltz C.D., Fischer E.H. Purification of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Chem. 1988, 263:6722-6730.
10. Bandyopadhyay D., Kusari A., Kenner K.A., et al. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J. Biol. Chem. 1997, 272:1639-1645.
11. Goldstein B.J., Bittner-Kowalczyk A., White M.F., et al. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J. Biol. Chem. 2000, 275:4283-4289.
12. Zabolotny J.M., Bence-Hanulec K.K., Stricker-Krongrad A., et al. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2002, 2:489-495.
13. Lund I.K., Hansen J.A., Andersen H.S., et al. Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J. Mol. Endocrinol. 2005, 34:339-351.
14. Kenner K.A., Anyanwu E., Olefsky J.M., et al. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J. Biol. Chem. 1996, 271:19810-19816.
15. Byon J.C., Kusari A.B., Kusari J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol. Cell. Biochem. 1998, 182:101-108.
16. Echwald S.M., Bach H., Vestergaard H., et al. A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 2002, 51:1-6.
17. Meshkani R., Taghikhani M., Al-Kateb H., et al. Polymorphisms within the protein tyrosine phosphatase 1B (PTPN1) gene promoter: functional characterization and association with type 2 diabetes and related metabolic traits. Clin. Chem. 2007, 53:1585-1592.
18. Di Paola R., Frittitta L., Miscio G., et al. A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am. J. Hum. Genet. 2002, 70:806-812.
19. Elchebly M., Payette P., Michaliszy E., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
20. Klaman L.D., Boss O., Peroni O.D., et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 2000, 20:5479-5489.
21. Bence K.K., Delibegovic M., Xue B., et al. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 2006, 12:917-924.
22. Khan N., Mukhtar H. Tea polyphenols for health promotion. Life Sci. 2007, 81:519-533.
23. Chen D., Milacic V., Chen M.S., et al. Tea polyphenols, their biological effects and potential molecular targets. Histol. Histopathol. 2008, 23:487-496.
24. Chacko S.M., Thambi P.T., Kuttan R., et al. Beneficial effects of green tea: a literature review. Chin. Med. 2010, 5:13.
25. Kao Y.H., Chang H.H., Lee M.J., et al. Tea, obesity, and diabetes. Mol. Nutr. Food Res. 2006, 50:188-210.
26. Huxley R., Lee C.M., Barzi F., et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch. Intern. Med. 2009, 169:2053-2063.
27. Yang M., Wang C., Chen H. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J. Nutr. Biochem. 2001, 12:14-20.
28. Wu L.Y., Juan C.C., Hwang L.S., et al. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur. J. Nutr. 2004, 43:116-124.
29. Song E.K., Hur H., Han M.K. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch. Pharm. Res. 2003, 26:559-563.
30. Shoji Y., Nakashima H. Glucose-lowering effect of powder formulation of African black tea extract in KK-A(y)/TaJcl diabetic mouse. Arch. Pharm. Res. 2006, 29:786-794.
31. Ramadan G., El-Beih N.M., Abd El-Ghffar E.A. Modulatory effects of black vs. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models. Br. J. Nutr. 2009, 102:1611-1619.
32. Tamaya K., Matsui T., Toshima A., et al. Suppression of blood glucose level by a new fermented tea obtained by tea-rolling processing of loquat (Eriobotrya japonica) and green tea leaves in disaccharide-loaded Sprague-Dawley rats. J. Sci. Food Agric. 2010, 90:779-783.
33. Fenercioglu A.K., Saler T., Genc E., et al. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications. J. Endocrinol. Invest. 2010, 33:118-124.
34. Grove K.A., Lambert J.D. Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity. J. Nutr. 2010, 140:446-453.
35. Odegaard A.O., Pereira M.A., Koh W.P., et al. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am. J. Clin. Nutr. 2008, 88:979-985.
36. Josic J., Olsson A.T., Wickeberg J., et al. Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: a randomized controlled trial. Nutr. J. 2010, 9:63.
37. Zhao Z., Bouchard P., Diltz C.D., et al. Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. J. Biol. Chem. 1993, 268:2816-2820.
38. Zhao Z., Larocque R., WT Ho., et al. Purification and characterization of PTP2C, a widely distributed protein tyrosine phosphatase containing two SH2 domains. J. Biol. Chem. 1994, 269:8780-8785.
39. Lambert I.H. Reactive oxygen species regulate swelling-induced taurine efflux in NIH3T3 mouse fibroblasts. J. Membr. Biol. 2003, 192:19-32.
40. Boyle J.P., Thompson T.J., Gregg E.W., et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 2010, 22:29.
41. Hill A.L., Rand D.G., Nowak M.A., et al. Infectious disease modeling of social contagion in networks. PLoS Comput. Biol. 2010, 6:e1000968.